Pediatric Musculoskeletal Research: Growth Plates, Bone Health and Sports Injuries
Pediatric musculoskeletal research examines how growing bones, joints and connective tissues respond to development, physical activi...
Retatrutide Triple-Agonist Research: Clinical Evidence, Safety and Canada Status
Retatrutide clinical research examines an investigational triple receptor agonist that targets GIP, GLP-1 and glucagon signalling. T...
Social Determinants of Health Research: Poverty, Nutrition and Health Outcomes
Social determinants of health research helps explain how poverty, food security, housing and employment shape population outcomes. F...
Bone Health Nutrition for Athletes: What World Osteoporosis Day Means for Lifters
Contents
Why Bone Health Nutrition for Athletes Matters More Than You Think
Calcium: The Headline Mineral in Bone Health Nut...
How to Store and Reconstitute Research Peptides: Bacteriostatic Water, Temperature, and Shelf Life
Lyophilised peptides keep best sealed, dry, dark and frozen. This lab guide covers storage temperatures, diluent choice for assays, aliquoting, freeze-thaw and why there is no universal shelf life.
Petrelintide in ZUPREME-2: Weight Loss, Gut Tolerability and the Next Amylin Test
petrelintide produced 7.4–9.2% mean weight loss in ZUPREME-2. Read the company-reported 28-week results, tolerability limits and next trials.
Peptides in Canada: Understanding Health Canada Authorization, Clinical Research and Regulatory Status
Understanding peptides in canada requires separating scientific research, clinical investigation and regulatory authorization. Some ...
BPC-157 Recovery Claims: What Human Evidence Actually Exists?
The human evidence for bpc 157 recovery claims remains extremely limited. A small number o...
Peptides in Canada: A Practical Guide to Approval, Research and Regulatory Status
Peptide science now spans two very different worlds.
On one side are established prescription medicines produced under regula...
EloraTZP Explained: Why Amylin + GIP/GLP-1 Is the Next Metabolic Research Frontier
New Phase 2b EloraTZP data combine eloralintide's amylin pathway with tirzepatide's GIP/GLP-1 activity. Here's what the 48-week results show and what Phase 3 must answer.